Literature selection
The literature search yielded a total of 1,065 citations. After deduplication, titles and abstracts of 764 citations were screened. Then, 185 publications proceeded to full-text eligibility assessment. Finally, 106 SRs fulfilled the eligibility criteria and were included (eTable 4, Additional file 1). Details on literature selection are illustrated in Fig. 1. A full list of excluded records is presented in eTable 5, Additional file 1.
Bibliographical characteristics of the included systematic reviews
The 106 included SRs contained 1,864 randomised controlled trials with 204,784 participants. Only five SRs (4.7%) were Cochrane reviews. Nineteen SRs (17.9%) were an update of previous SRs. The median publication year was 2019. Impact factor ranged from 0 to 6.8 with a median of 2.0. Number of review authors ranged from two to 13 with a median of six. The corresponding authors of 93 (87.7%) SRs were from Asia, seven (6.6%) from America, four (3.8%) from Europe, and two (1.9%) from Oceania. Over a half (66; 62.3%) of the SRs had their funding sources located in Asia, while 24 (22.6%) SRs did not receive any funding support.
One-hundred-and-five (99.1%) SRs involved English database searching, while 88 (83.0%) involved non-English database searching. Most SRs reported both starting and ending years of search (81; 76.4%) and search terms for one or more electronics databases (101; 95.2%). Seventy-six (71.7%) SRs reported intervention harms. Nevertheless, 59 (55.7%) SRs did not report the language of the included primary studies.
Ninety-nine (93.4%) applied the Cochrane risk-of-bias tool for assessing risk of bias, two used Jadad scale (1.9%) or Pedro scale (1.9%) respectively, and two did not perform risk of bias assessment (1.9%). One-hundred-and-two (96.2%) SRs included a PRISMA-like flow diagram to illustrate the process of literature selection. Details on bibliographical characteristics are shown in Table 1.
Table 1
Bibliographical characteristics of the 106 included systematic reviews on acupuncture
Bibliographical characteristics | Results* |
Cochrane review | 5 (4.7) |
An update of previous review | 19 (17.9) |
An update of previous Cochrane review | 3 (2.8) |
An update of a previous non-Cochrane review | 16 (15.1) |
Publication year median (range) | 2019 (2018–2020) |
Publication journal impact factor median (range) | 2.0 (0-6.8) |
Number of review authors median (range) | 6 (2–13) |
Location of corresponding author | |
Europe | 4 (3.8) |
America | 7 (6.6) |
Asia | 93 (87.7) |
Oceania | 2 (1.9) |
Number of included primary studies | |
Total | 1864 |
Median (range) | 13.5 (3–73) |
Number of participants included in primary studies | |
Total | 204784 |
Median (range) | 1238 (178–20827) |
SRs reporting intervention harms | 76 (71.7) |
Funding location of the SR | |
Europe | 4 (3.8) |
America | 4 (3.8) |
Asia | 66 (62.3) |
Not reported | 8 (7.5) |
No funding support | 24 (22.6) |
SRs that searched English databases | 105 (99.1) |
SRs that searched non-English databases | 88 (83.0) |
Report year span of search | |
Yes, reported both starting and ending years | 81 (76.4) |
Partially, only reported starting years | 19 (17.9) |
Not mentioned | 6 (5.7) |
Search terms reported for one or more electronic databases | |
Topics/free text/keywords/MeSH | 47 (44.3) |
Full Boolean | 54 (50.9) |
Readers are referred elsewhere for full search strategy | 0 (0) |
No research term | 5 (4.7) |
Language of included primary studies in SRs | |
English only | 9 (8.5) |
Language other than English | 6 (5.7) |
English and other languages | 32 (30.2) |
Not reported | 59 (55.7) |
Risk of bias assessment tools | |
Cochrane risk of bias | 99 (93.4) |
Jadad scale | 2 (1.9) |
Pedro Scale | 2 (1.9) |
Others | 1 (0.9) |
Risk of bias assessment tool not used | 2 (1.9) |
Included a PRISMA-like flow diagram | 102 (96.2) |
MeSH: Medicine Medical Subject Headings; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-analysis; SR: Systematic review. |
*Values are n (%) or median (range). |
Methodological quality
Performance among the included SRs was inadequate across four of the seven AMSTAR 2 critical domains, with that less than 20% satisfying the following: ten (9.4%) SRs established an a priori protocol and justified deviations from the protocol (item 2); four (3.8%) implemented a comprehensive literature search strategy (item 4); five (4.7%) listed excluded studies and justified the exclusions (item 7); and six (5.7%) conducted appropriate meta-analysis (item 11).
Included SRs performed relatively better across the remaining three critical domains: 97 (91.5%) had the risk of bias of individual studies assessed by appropriate instruments (item 9); 78 (73.6%) accounted for risk of bias among individual studies when interpreting results (item 13); and 23 (21.7%) investigated publication bias, and discussed its potential impact on the results (item 15).
Performance was unsatisfactory among four of the nine non-critical domains, with less than 20% fulfilling relevant criteria: four (3.8%) explained the selection of study designs for inclusion (item 3); 12 (11.3%) described included studies in adequate details (item 8); four (3.8%) reported sources of funding among individual studies included (item 10); and 19 (17.9%) assessed potential impact of risk of bias among individual studies on the results of meta-analysis (item 12).
More than 75% of SRs performed well across the remaining five non-critical domains: all SRs reported the PICO components (Problem/Patient/Population, Intervention/Indicator, Comparison, and Outcome) in their research questions and inclusion criteria (item 1); 94 (88.7%) and 97 (91.5%) SRs performed study selection (item 5) and data extraction (item 6) in duplicate, respectively; 84 (79.2%) provided a satisfactory explanation for heterogeneity in the results (item 14); and nearly all (104; 98.1%) reported the potential sources of conflict of interest (item 16). Details on the results of the AMSTAR 2 items are illustrated in Table 2.
Table 2
Results of the AMSTAR-2 items for the 106 systematic reviews on acupuncture
AMSTAR- 2 items | Yes (%) | Partial Yes (%) | No (%) |
1. Did the research questions and inclusion criteria for the review include the components of PICO? | 106 (100) | NA | 0 (0) |
2. Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol?* | 10 (9.4) | 32 (30.2) | 64 (60.4) |
3. Did the review authors explain their selection of the study designs for inclusion in the review? | 4 (3.8) | NA | 102 (96.2) |
4. Did the review authors use a comprehensive literature search strategy?* | 4 (3.8) | 99 (93.4) | 3 (2.8) |
5. Did the review authors perform study selection in duplicate? | 94 (88.7) | NA | 12 (11.3) |
6. Did the review authors perform data extraction in duplicate? | 97 (91.5) | NA | 9 (8.5) |
7. Did the review authors provide a list of excluded studies and justify the exclusions?* | 5 (4.7) | 1 (0.9) | 100 (94.3) |
8. Did the review authors describe the included studies in adequate detail? | 12 (11.3) | 84 (79.2) | 10 (9.4) |
9. Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review?* | 97 (91.5) | 3 (2.8) | 6 (5.7) |
10. Did the review authors report on the sources of funding for the studies included in the review? | 4 (3.8) | NA | 102 (96.2) |
11. If meta-analysis was performed, did the review authors use appropriate methods for statistical combination of results?* | 6 (5.7) | NA | 100 (94.3) |
12. If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis? | 19 (17.9) | NA | 87 (82.1) |
13. Did the review authors account for RoB in individual studies when interpreting / discussing the results of the review?* | 78 (73.6) | NA | 28 (26.4) |
14. Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? | 84 (79.2) | NA | 22 (20.8) |
15. If they performed quantitative synthesis, did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review?* | 23 (21.7) | NA | 83 (78.3) |
16. Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review? | 104 (98.1) | NA | 2 (1.9) |
AMSTAR 2: A MeaSurement Tool to Assess systematic Reviews 2; NA: Not applicable. |
*Critical domain-specific item. |
Relationship between bibliographical characteristics and overall methodological quality
Among the 106 appraised SRs, only one (0.9%) of them was of high overall methodological quality, while six (5.7%) were of low-quality. The remaining 99 (93.4%) SRs were of critically low-quality.
Results of Kruskal-Wallis tests indicated that there were statistically significant between-group differences across five bibliographical characteristics [Table 3]. Cochrane reviews (p < 0.001), an update of a previous non-Cochrane review (p = 0.007), SRs published in 2018 (p = 0.014), SRs with corresponding authors from America (p = 0.028), and SRs that searched non-English databases (p = 0.048) had higher overall methodological quality than their counterparts. The Spearman's rank correlation coefficient also showed that SRs published in higher impact factor journals (rs = 0.36; p < 0.001) were associated with higher overall methodological quality.
Table 3
Overall methodological quality of the 106 systematic reviews on acupuncture by bibliographical characteristics
Bibliographical characteristics | Critically low^ | Low^ | Moderate^ | High^ | P |
Total included SRs | 99 (93.4) | 6 (5.7) | 0 (0.0) | 1 (0.9) | |
Cochrane Review | < 0.001* |
Yes | 0 (0.0) | 4 (80.0) | 0 (0.0) | 1 (20.0) | |
No | 99 (98.0) | 2 (2.0) | 0 (0.0) | 0 (0) | |
An update of a previous review | 0.007* |
Yes (Cochrane review) | 3 (100) | 0 (0) | 0 (0.0) | 0 (0.0) | |
Yes (non-Cochrane review) | 12 (75.0) | 3 (18.8) | 0 (0.0) | 1 (6.3) | |
No | 84 (96.6) | 3 (3.4) | 0 (0.0) | 0 (0.0) | |
Published year | 0.014* |
2018 | 40 (85.1) | 6 (12.8) | 0 (0.0) | 1 (2.1) | |
2019 | 49 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
2020 | 10 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Location of corresponding author | 0.028* |
Europe | 4 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
America | 6 (85.7) | 0 (0.0) | 0 (0.0) | 1 (14.3) | |
Asia | 87 (93.5) | 6 (6.5) | 0 (0.0) | 0 (0.0) | |
Oceania | 2 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Reported intervention harms | 0.659 |
Yes | 70 (92.1) | 5 (6.6) | 0 (0.0) | 1 (1.3) | |
No | 29 (96.7) | 1 (3.3) | 0 (0.0) | 0 (0.0) | |
Funding location of the SR | 0.859 |
Europe | 4 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
America | 4 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Asia | 61 (92.4) | 4 (6.1) | 0 (0.0) | 1 (1.5) | |
Not reported | 7 (87.5) | 1 (12.5) | 0 (0.0) | 0 (0.0) | |
No funding support | 23 (95.8) | 1 (4.2) | 0 (0.0) | 0 (0.0) | |
SRs that searched non-English databases | 0.048* |
Yes | 82 (93.2) | 6 (6.8) | 0 (0.0) | 0 (0.0) | |
No | 17 (94.4) | 0 (0.0) | 0 (0.0) | 1 (5.6) | |
Report year of coverage of literature search | 0.323 |
Yes | 74 (91.4) | 6 (7.4) | 0 (0.0) | 1 (1.2) | |
Partially | 19 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Not mentioned | 6 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Search terms reported for one or more electronic databases | 0.287 |
Topics/free text/keywords/MeSH | 47 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Full Boolean | 48 (88.9) | 5 (9.3) | 0 (0.0) | 1 (1.9) | |
Readers are referred elsewhere for full search strategy | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
No research term | 4 (80.0) | 1 (20.0) | 0 (0.0) | 0 (0.0) | |
Eligibility criteria based on language of publication | 0.467 |
English only | 9 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Language other than English | 5 (83.3) | 1 (16.7) | 0 (0.0) | 0 (0.0) | |
English and other languages | 28 (87.5) | 3 (9.4) | 0 (0.0) | 1 (3.1) | |
Not reported | 57 (96.6) | 2 (3.4) | 0 (0.0) | 0 (0.0) | |
Risk-of-bias assessment tools | 0.769 |
Cochrane risk of bias | 92 (92.9) | 6 (6.1) | 0 (0.0) | 1 (1.0) | |
Jadad scale | 2 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Pedro Scale | 2 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Others | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Not mentioned | 2 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Included a PRISMA-like flow diagram | 0.865 |
Yes | 95 (93.1) | 6 (5.9) | 0 (0.0) | 1 (1.0) | |
No | 4 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
MeSH: National Library of Medicine Medical Subject Headings; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-analysis; SR: Systematic review. |
^Values are n (% in subgroup). |
*P value of Kruskal-Wallis test was < 0.05. |